Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Toll-like receptor mediated regulation of breast cancer: a case of mixed blessings.

Yusuf N.

Front Immunol. 2014 May 16;5:224. doi: 10.3389/fimmu.2014.00224. eCollection 2014. Review. No abstract available.

2.

Identification and quantification of innate immune system mediators in human breast milk.

Armogida SA, Yannaras NM, Melton AL, Srivastava MD.

Allergy Asthma Proc. 2004 Sep-Oct;25(5):297-304.

PMID:
15603202
3.

Single-nucleotide polymorphisms in genes encoding toll-like receptor -2, -3, -4, and -9 in case-control study with breast cancer.

Etokebe GE, Knezević J, Petricević B, Pavelić J, Vrbanec D, Dembić Z.

Genet Test Mol Biomarkers. 2009 Dec;13(6):729-34. doi: 10.1089/gtmb.2009.0045.

PMID:
19810822
4.

Contribution of toll-like receptor signaling pathways to breast tumorigenesis and treatment.

Kidd LC, Rogers EN, Yeyeodu ST, Jones DZ, Kimbro KS.

Breast Cancer (Dove Med Press). 2013 Jun 28;5:43-51. doi: 10.2147/BCTT.S29172. eCollection 2013. Review.

5.

[Frontier of mycobacterium research--host vs. mycobacterium].

Okada M, Shirakawa T.

Kekkaku. 2005 Sep;80(9):613-29. Japanese.

PMID:
16245793
6.

Toll-like receptor (TLR) expression of immune system cells from metastatic breast cancer patients with circulating tumor cells.

Green TL, Santos MF, Ejaeidi AA, Craft BS, Lewis RE, Cruse JM.

Exp Mol Pathol. 2014 Aug;97(1):44-8. doi: 10.1016/j.yexmp.2014.05.003. Epub 2014 May 14.

PMID:
24836676
7.

Regulation of innate immune responses by Toll-like receptors.

Takeda K, Akira S.

Jpn J Infect Dis. 2001 Dec;54(6):209-19. Review.

PMID:
11862002
8.

Defects in innate immunity render breast cancer initiating cells permissive to oncolytic adenovirus.

Ahtiainen L, Mirantes C, Jahkola T, Escutenaire S, Diaconu I, Osterlund P, Kanerva A, Cerullo V, Hemminki A.

PLoS One. 2010 Nov 5;5(11):e13859. doi: 10.1371/journal.pone.0013859.

9.

Comparative analysis of innate immune system function in metastatic breast, colorectal, and prostate cancer patients with circulating tumor cells.

Santos MF, Mannam VK, Craft BS, Puneky LV, Sheehan NT, Lewis RE, Cruse JM.

Exp Mol Pathol. 2014 Jun;96(3):367-74. doi: 10.1016/j.yexmp.2014.04.001. Epub 2014 Apr 13.

PMID:
24731923
10.
11.

Innate and adaptive immune correlates of vaccine and adjuvant-induced control of mucosal transmission of SIV in macaques.

Sui Y, Zhu Q, Gagnon S, Dzutsev A, Terabe M, Vaccari M, Venzon D, Klinman D, Strober W, Kelsall B, Franchini G, Belyakov IM, Berzofsky JA.

Proc Natl Acad Sci U S A. 2010 May 25;107(21):9843-8. doi: 10.1073/pnas.0911932107. Epub 2010 May 10.

12.

Therapeutic targeting of innate immunity with Toll-like receptor agonists and antagonists.

Kanzler H, Barrat FJ, Hessel EM, Coffman RL.

Nat Med. 2007 May;13(5):552-9. Review.

PMID:
17479101
13.

Sequence variants in Toll-like receptor gene cluster (TLR6-TLR1-TLR10) and prostate cancer risk.

Sun J, Wiklund F, Zheng SL, Chang B, Bälter K, Li L, Johansson JE, Li G, Adami HO, Liu W, Tolin A, Turner AR, Meyers DA, Isaacs WB, Xu J, Grönberg H.

J Natl Cancer Inst. 2005 Apr 6;97(7):525-32.

PMID:
15812078
14.

Intact gram-negative Helicobacter pylori, Helicobacter felis, and Helicobacter hepaticus bacteria activate innate immunity via toll-like receptor 2 but not toll-like receptor 4.

Mandell L, Moran AP, Cocchiarella A, Houghton J, Taylor N, Fox JG, Wang TC, Kurt-Jones EA.

Infect Immun. 2004 Nov;72(11):6446-54.

15.

Innate immunity: sensing the environment and regulating the regulators.

Vercelli D.

Curr Opin Allergy Clin Immunol. 2003 Oct;3(5):343-6. Review.

PMID:
14501432
16.
17.

Activation of Toll-like receptor 5 on breast cancer cells by flagellin suppresses cell proliferation and tumor growth.

Cai Z, Sanchez A, Shi Z, Zhang T, Liu M, Zhang D.

Cancer Res. 2011 Apr 1;71(7):2466-75. doi: 10.1158/0008-5472.CAN-10-1993. Epub 2011 Mar 22.

18.

Toll-like receptor 9 agonist inhibits ERalpha-mediated transactivation by activating NF-kappaB in breast cancer cell lines.

Qiu J, Wang X, Guo X, Zhao C, Wu X, Zhang Y.

Oncol Rep. 2009 Oct;22(4):935-41.

PMID:
19724876
19.

Impaired Toll-like receptor 2 signalling in monocytes from 5-year-old allergic children.

Amoudruz P, Holmlund U, Saghafian-Hedengren S, Nilsson C, Sverremark-Ekström E.

Clin Exp Immunol. 2009 Mar;155(3):387-94. doi: 10.1111/j.1365-2249.2008.03792.x.

20.

Innate adjuvant receptor Toll-like receptor 3 can promote breast cancer through cell surface.

Bondhopadhyay B, Moirangthem A, Basu A.

Tumour Biol. 2015 Feb;36(2):1261-71. doi: 10.1007/s13277-014-2737-8. Epub 2014 Oct 28.

PMID:
25348355

Supplemental Content

Support Center